DrugPatentWatch Database Preview

Litigation for AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE

Email this page to a colleague

« Back to Dashboard

US Court Litigation for AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE

Patent	Case Name	Docket	Date Filed	Date Terminated	Cause	Court	Jury Demand	Link To Docket
8,163,723	Meda Pharmaceuticals Inc. v. Apotex Inc.		2014-12-02		28:2201 Declaratory Judgment	District Court, D. Delaware	None
8,163,723	Meda Pharmaceuticals Inc. v. Apotex Inc.		2014-12-02		28:2201 Declaratory Judgment	District Court, D. Delaware	None
8,163,723			2015-09-08		35:145 Patent Infringement	District Court, D. Delaware	None
8,168,620	Meda Pharmaceuticals Inc. v. Apotex Inc.		2014-12-02		28:2201 Declaratory Judgment	District Court, D. Delaware	None
8,168,620	Meda Pharmaceuticals Inc. v. Apotex Inc.		2014-12-02		28:2201 Declaratory Judgment	District Court, D. Delaware	None

Patent Trial and Appeal Board Cases for AZELASTINE HYDROCHLORIDE; FLUTICASONE PROPIONATE

Patent	Petitioner	Status	Filing Date	Accorded Filing Date	Patent Owner	Trial Type	Trial Number	Decision Date	Inventor	Document Download
8,163,723	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC		2020-01-31	01-31-2020	Lulla et al	Inter partes review
8,168,620			2017-02-02	02-02-2017	Lulla et al	Inter partes review		08-21-2017
8,168,620	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC		2020-01-31	01-31-2020	Lulla et al	Inter partes review
9,259,428	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC		2020-01-31	01-31-2020	LULLA et al	Inter partes review
9,901,585	GlaxoSmithKline Consumer Healthcare Holdings (US) LLC		2020-01-31	01-31-2020	LULLA et al	Inter partes review